psilocybin has been researched along with Obsessive-Compulsive Disorder in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, JJB; Ehrmann, K; Moreno, FA | 1 |
| Aaronson, ST; Kirlic, N; Lennard-Jones, M; Miller, TM; Modlin, NL; Rucker, JJ; Schlosser, D | 1 |
| Botvinnik, A; Lerer, B; Lifschytz, T; Lotan, A; Saban, M; Salama, A; Shahar, O; Singh, S; Wolf, G; Yakobi, C | 1 |
| Bayat, M | 1 |
| Flanagan, TW; Nichols, CD | 1 |
| Andreassen, OA; Kvam, TM; Stewart, LH | 1 |
| Johnson, MW; Nichols, CD; Nichols, DE | 1 |
| DELAY, J; LEMPERIERE, T; PICHOT, P; QUETIN, AM | 1 |
| Delgado, PL; Moreno, FA; Taitano, EK; Wiegand, CB | 1 |
| Delgado, PL; Moreno, FA | 1 |
| Perrine, DM | 1 |
| Leonard, HL; Rapoport, JL | 1 |
4 review(s) available for psilocybin and Obsessive-Compulsive Disorder
| Article | Year |
|---|---|
Psilocybin for the Treatment of Obsessive-Compulsive Disorders.
Topics: Hallucinogens; Humans; Obsessive-Compulsive Disorder; Prospective Studies; Psilocybin | 2022 |
[Classic psychedelic drugs and their potential therapeutic effect].
Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Cluster Headache; Depression; Hallucinogens; Humans; Lysergic Acid Diethylamide; Obsessive-Compulsive Disorder; Psilocybin; Receptor, Serotonin, 5-HT2A; Substance-Related Disorders | 2017 |
Psychedelic drugs in the treatment of anxiety, depression and addiction.
Topics: Anxiety; Anxiety Disorders; Depression; Depressive Disorder; Hallucinogens; Humans; Lysergic Acid Diethylamide; Obsessive-Compulsive Disorder; Psilocybin; Substance-Related Disorders | 2018 |
Psychedelics as Medicines: An Emerging New Paradigm.
Topics: Anxiety; Brain; Clinical Trials as Topic; Depression; Dose-Response Relationship, Drug; Hallucinogens; Humans; Inflammation; Inflammation Mediators; Lysergic Acid Diethylamide; Mental Disorders; Mind-Body Therapies; Obsessive-Compulsive Disorder; Psilocybin; Psychotherapy; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Agonists; Severity of Illness Index; Substance-Related Disorders | 2017 |
1 trial(s) available for psilocybin and Obsessive-Compulsive Disorder
| Article | Year |
|---|---|
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.
Topics: Adult; Analysis of Variance; Double-Blind Method; Female; Hallucinogens; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Pain Measurement; Psilocybin; Severity of Illness Index; Treatment Outcome | 2006 |
7 other study(ies) available for psilocybin and Obsessive-Compulsive Disorder
| Article | Year |
|---|---|
Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparation.
Topics: Anxiety; Depressive Disorder, Major; Hallucinogens; Humans; Obsessive-Compulsive Disorder; Psilocybin | 2023 |
Effect of psilocybin on marble burying in ICR mice: role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Buspirone; Escitalopram; Hallucinogens; Male; Mice; Mice, Inbred ICR; Obsessive-Compulsive Disorder; Psilocybin; Receptor, Serotonin, 5-HT1A; Serotonin | 2023 |
Psychedelics as anti-inflammatory agents.
Topics: Amphetamines; Animals; Anti-Inflammatory Agents; Anxiety; Behavior, Animal; Depression; Hallucinogens; Humans; Obsessive-Compulsive Disorder; Psilocybin; Receptor, Serotonin, 5-HT2A | 2018 |
[Therapeutic effect of psilocybin on convulsive neurosis].
Topics: Hallucinogens; Humans; Indoles; Neurotic Disorders; Obsessive-Compulsive Disorder; Psilocybin | 1959 |
Hallucinogen-induced relief of obsessions and compulsions.
Topics: Adult; Humans; Male; Mescaline; Obsessive-Compulsive Disorder; Psilocybin; Self Medication; Substance-Related Disorders | 1997 |
Hallucinogens and obsessive-compulsive disorder.
Topics: Adult; Anorexia Nervosa; Hallucinogens; Humans; Male; Mescaline; Obsessive-Compulsive Disorder; Psilocybin; Treatment Outcome | 1999 |
Relief of obsessive-compulsive symptoms by LSD and psilocin.
Topics: Adolescent; Humans; Lysergic Acid Diethylamide; Male; Obsessive-Compulsive Disorder; Psilocybin; Serotonin; Substance-Related Disorders | 1987 |